MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent director Stan V. Smith, ...
VIENNA, Va., Nov. 7, 2024 /PRNewswire/ -- USX Cyber has unveiled a transformative all-in-one pricing model for its GUARDIENT™ Extended Detection and Response (XDR) platform, which consolidates all ...